Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase
Open Access
- 1 April 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (4), 836-839
- https://doi.org/10.1038/bjc.1995.161
Abstract
We report DNA interstrand cross-linking caused by the anti-tumour indoloquinone EO9 following reductive activation with purified rat liver DT-diaphorase or xanthine oxidase. Reduction was a necessary event for cross-linking to occur. DNA cross-link formation by EO9 following DT-diaphorase reduction was completely inhibited by addition 10 microM dicoumarol, whereas only a minor effect of dicoumarol on xanthine oxidase-mediated DNA cross-linking by EO9 was observed. DNA cross-linking was pH dependent, with increasing cross-link formation from pH 5.5 to 7.0 for both DT-diaphorase and xanthine oxidase mediated reactions. Also, conversion of EO9 upon reduction was pH dependent. However, in contrast to DNA cross-linking, conversion rates of EO9 decreased at higher pH. EO9 was shown to be more efficient in DNA cross-linking than mitomycin C under identical conditions, using both DT-diaphorase and xanthine oxidase reductive activation at pH 5.5 and 7.0. This study indicates that the anti-tumour activity of EO9 may be at least partly mediated by interstrand DNA cross-link formation, and that various reducing enzymes may be important for activation of EO9 in vitro and in vivo.Keywords
This publication has 17 references indexed in Scilit:
- DT-diaphorase in activation and detoxification of quinonesCancer and Metastasis Reviews, 1993
- Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: Indoloquinones and diaziridinyl benzoquinonesInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Keynote address: Bioreductive mechanismsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?Biochemical Pharmacology, 1992
- In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicityBritish Journal of Cancer, 1992
- High levels of expression of the NAD(P)H:Quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same originBiochemical Pharmacology, 1991
- The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09Cancer Communications, 1991
- Reductive activation of potential antitumor bis(aziridinyl)benzoquinones by xanthine oxidase: Competition between oxygen reduction and quinone reductionArchives of Biochemistry and Biophysics, 1990
- Purification by cibacron blue F3GA dye affinity chromatography and comparison of NAD(P)H:quinone reductase (E.C.1.6.99.2) from rat liver cytosol and microsomesBiochemical and Biophysical Research Communications, 1989
- One-electron transfer reactions in biochemical systems. VII. Two types of electron outlets in milk xanthine oxidaseBiochimica et Biophysica Acta (BBA) - Enzymology, 1973